Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-20-049712
Filing Date
2020-04-22
Accepted
2020-04-22 16:11:31
Documents
5

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2016455d1_s3.htm S-3 281706
2 EXHIBIT 5.1 tm2016455d1_ex5-1.htm EX-5.1 7362
3 EXHIBIT 23.1 tm2016455d1_ex23-1.htm EX-23.1 2346
4 GRAPHIC wr-logo.jpg GRAPHIC 2418
5 GRAPHIC logo.gif GRAPHIC 7777
  Complete submission text file 0001104659-20-049712.txt   306552
Mailing Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017
Business Address 295 MADISON AVENUE, SUITE 2400 NEW YORK NY 10017 813-766-9539
EYENOVIA, INC. (Filer) CIK: 0001682639 (see all company filings)

EIN.: 471178401 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-237790 | Film No.: 20808070
SIC: 2834 Pharmaceutical Preparations